Lawrence Wennogle Net Worth & Insider Trades

Lawrence Wennogle - Vice President, Intra-Cellular Therapies, Inc

As of June 9, 2015

What is Lawrence Wennogle's Net Worth?

The current estimated net worth of Intra-Cellular Therapies, Inc's Vice President, Lawrence Wennogle, is estimated to be about $8.87M . Lawrence Wennogle owns about 126,500 units of Intra-Cellular Therapies, Inc common stock. In the last year at Intra-Cellular Therapies, Inc, Lawrence Wennogle has sold an estimated value of $1.36M worth.

What is Lawrence Wennogle's Past Insider Trading?

Lawrence Wennogle's largest sale order was 25,000 units , worth over $671K on June 9, 2015. In total, Lawrence Wennogle has made about 12 transactions over a year of their time at Intra-Cellular Therapies, Inc. Lawrence Wennogle usually trades in October, with the busiest year in 2014.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Lawrence Wennogle's Salary in 2020?

As Vice President of Intra-Cellular Therapies, Inc, Lawrence Wennogle has a total base salary of $463,400 . Lawrence Wennogle received compensation valued at about $2,206,183 in 2020 after becoming Vice President. The vast majority of their compensation came in the form of a bonus of $222,432 , stock awards of $1,049,984 , option awards of $449,993 , and other compensation of $20,374 .

What is Lawrence Wennogle's' Mailing Address?

  • Mailing address is C/o Intra-Cellular Therapies, Inc. 3960 Broadway New York NY 10032 NY

Intra-Cellular Therapies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Sharon Mates, Ph.D. 2020 $766,800 $690,120 $2,799,998 $1,199,994 $18,767 $5,475,679
Sharon Mates, Ph.D. 2019 $744,500 $759,400 $1,599,996 $1,600,003 $20,661 $4,724,560
Sharon Mates, Ph.D. 2018 $722,800 $585,500 $1,593,735 $1,556,410 $18,024 $4,476,469
Lawrence J. Hineline 2020 $463,400 $222,432 $1,049,984 $449,993 $20,374 $2,206,183
Lawrence J. Hineline 2019 $449,900 $225,000 $749,988 $749,995 $18,648 $2,193,531
Lawrence J. Hineline 2018 $424,400 $203,700 $749,986 $732,430 $17,292 $2,127,808
Suresh Durgam, M.D. 2020 $448,575 $274,400 $599,984 $599,997 $7,385 $1,930,341
Michael I. Halstead 2020 $512,000 $320,000 $1,119,985 $479,990 $17,931 $2,449,906
Michael I. Halstead 2019 $497,100 $323,100 $749,988 $749,995 $17,270 $2,337,453
Michael I. Halstead 2018 $469,000 $225,100 $749,986 $732,430 $16,680 $2,193,196
Mark Neumann 2020 $518,900 $324,312 $1,119,985 $479,990 $130,085 $2,573,272
Mark Neumann 2019 $503,800 $277,100 $799,991 $799,997 $133,449 $2,514,337
Mark Neumann 2018 $106,090 $245,500 $749,995 $749,990 $25,124 $1,876,699
Andrew Satlin, M.D. 2020 $480,634 $0 $1,119,985 $479,990 $20,585 $2,101,194
Andrew Satlin, M.D. 2019 $515,000 $360,500 $874,997 $874,996 $19,332 $2,644,825
Andrew Satlin, M.D. 2018 $500,000 $300,000 $0 $0 $11,792 $811,792
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1567514/000119312521140765/d80913ddef14a.htm

What are Intra-Cellular Therapies, Inc's Past Insider Trades?

Intra-Cellular Therapies, Inc's most recent insider trade came on September 23, 2022 by Lawrence J Hineline who sold 65,164 units worth $2.97M . In the last 8 years, insiders at Intra-Cellular Therapies, Inc have sold an estimated value of $102.72M and bought an estimated value of $62.82M worth of shares. Insider trading is most common in January, with the busiest year in 2020. The most active traders at the company are Christopher Alafi, Director,  Rory Riggs, Director,  and Robert Nostrand Van, Director .

Intra-Cellular Therapies, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1